People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Euphrates Vascular, Inc. | — | Biotechnology | Series A | $9.7M | $322.2M | 2018 |
| Ichor Vascular Inc. | — | Other Health Care | Seed | $3.1M | $15.7M | 2016 |
TROY LONG at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TROY LONG on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Blair | 2 | 2 |
| Robert Mitchell | 1 | 9 |
| Sean Morris | 1 | 7 |
| ERIC MOESSINGER | 1 | 6 |
| Mark Peterson | 1 | 5 |
| THOMAS HILLMAN | 1 | 3 |
| Surindra Mitruka | 1 | 2 |
| Andrew Greenfield | 1 | 2 |
| JEFF BLAIR | 1 | 2 |
| Martin Omid Akhavan | 1 | 2 |
| Tim Blair | 1 | 1 |
| Timothy Blair | 1 | 1 |
| Craig Berky | 1 | 1 |
| Cathy Omid Matthes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.